Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1050471Generated: November 3, 2026

1,2-Dichloroethane → HCID 178429081, compound

https://huagongshe.com/reaction/1050471

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1,2-DichloroethaneHCID 11—
Reactant4-MethylmorpholineHCID 7972—
ReactantSodium CarbonateHCID 10340—
ReactantHOAtHCID 181649—
Reactant3-(aminomethyl)-2,6-dimethylpyridin-4(1H)-one hydrochlorideHCID 90273227—
ReactantHCID 178431641HCID 178431641—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
SolventEthyl AcetateHCID 8857—
ProductHCID 178429081HCID 17842908126%

Reaction Steps

A 20 mL vial was charged with 5-chloro-3-(((trans)-4-(dimethylamino)cyclohexyl)oxy)-2-methylbenzoic acid (120 mg, 0.385 mmol), 3-(aminomethyl)-2,6-dimethylpyridin-4(1H)-one, hydrochloride (80 mg, 0.423 mmol), EDC (111 mg, 0.577 mmol), HOAT (89 mg, 0.577 mmol), N,N-dimethylformamide (DMF) (3 mL), and NMM (1.015 mL, 9.24 mmol). The reaction was stirred for 16 h, at which time it was poured into a stirring solution of water (5 mL) and sat Na2CO3 (20 mL). The mixture was stirred at room temperature 1 h, but no precipitate had formed. EtOAc was added and the layers were separated. White precipitate formed in the aqueous layer. The precipitate was filtered and determined to not be the title product. LCMS showed the product in both layers, so the layers were re-combined and concentrated in vacuo. The solid residue was diluted with MeOH (3 mL) and DMSO (1 mL) and the insolubles were filtered off. The solution was purified by reverse phase HPLC (Phenomenex Gemini-NX axia 30×100 mm, 5μ, C18; 15-45% acetonitrile/0.1% formic acid in water). Since the product was running close to the solvent front, the gradient was changed to 5-45% 0.1% formic acid in water/acetonitrile and the remaining sample was purified by this method. The desired fractions were concentrated to a glassy solid. The residue was dissolved in MeOH (3 mL) and filtered through ISOLUTE® Si-Carbonate (2 g) to remove the formic acid. The ISOLUTE® Si-Carbonate was washed with MeOH (3 mL) and the combined methanol layers were concentrated in vacuo. The ISOLUTE® Si-Carbonate filtration step was repeated and the MeOH washing concentrated in vacuo to give 5-chloro-N-((2,6-dimethyl-4-oxo-1,4-dihydropyridin-3-yl)methyl)-3-(((trans)-4-(dimethylamino)cyclohexyl)oxy)-2-methylbenzamide (45 mg, 0.100 mmol, 26.0% yield), as an off-white powder. 1H NMR (400 MHz, DMSO-d6) δ 11.08 (br. s., 1H), 8.22 (br. s., 1H), 7.11 (d, J=2.02 Hz, 1H), 6.78 (d, J=1.77 Hz, 1H), 5.87 (br. s., 1H), 4.27-4.41 (m, J=4.52, 4.52, 8.40 Hz, 1H), 4.19 (d, J=5.05 Hz, 2H), 2.31 (s, 3H), 2.17-2.21 (m, 1H), 2.17 (s, 6H), 2.16 (s, 3H), 2.03 (s, 5H), 1.78 (br. s., 2H), 1.37 (t, J=9.98 Hz, 4H). MS(ES) [M+H]+ 446.1.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09382234B2
Source datasetuspto-grants-2016_07
ORD IDord-4f4f4c53fa6a4217b902ceae52972aa0
Source noteuspto-grants-2016_07